“Since 2006 — five years after the start of major combat operations in Afghanistan and three years after the U.S.-led invasion of Iraq — a total of 16,652 active duty personnel and mobilized reservists have died while serving in the U.S. armed forces,” the Congressional Research Service said, based on data obtained from the Department of Defense. See Recent Trends in Active-Duty Military Deaths, CRS In Focus, updated May 20, 2019.
Other new and updated reports from the Congressional Research Service include the following.
Military Personnel and Extremism: Law, Policy, and Considerations for Congress, CRS Insight, updated May 16, 2019
United States Foreign Intelligence Relationships: Background, Policy and Legal Authorities, Risks, Benefits, May 15, 2019
Global Human Rights: The Department of State’s Country Reports on Human Rights Practices, CRS In Focus, updated May 20, 2019
Combating Corruption in Latin America: Congressional Considerations, May 21, 2019
Cuba: Trump Administration Expands Sanctions, CRS Insight, May 17, 2019
The European Parliament and U.S. Interests, CRS In Focus, May 16, 2019
Long Live Cash: The Potential Decline of Cash Usage and Related Implications, May 10, 2019
Electronic Messaging Recordkeeping Requirements, CRS In Focus, May 21, 2019
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.